Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Alternatives to Routine Follow-Up for Early Medical Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Comparison of serum markers for thrombophilia and autoimmune disease
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Acceptability and feasibility of medical abortion in Nepal
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Increasing women’s choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for incomplete abortion
Non-physician clinicians can safely provide first trimester medical abortion
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol after mifepristone
Abortion and sex determination
Two distinct oral routes of misoprostol in mifepristone medical abortion
Expanding Choice in Abortion Services in Armenia
Abortion in the Middle East and North Africa
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Integrating medical abortion into safe abortion services in South Africa
Fever after treatment of postpartum hemorrhage
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Social Science Research Activities Brief
Policy and Advocacy Activities Brief
Pregnancy Failure and Miscarriage Program Brief
Blood Loss After Vaginal Delivery
Community-based kangaroo mother care to prevent neonatal and infant mortality
Supervision for use of mifepristone medical abortion
STIs/ HIV/ Infectious Disease Program Brief
Training and Education Activities Brief
Technical Assistance Activities Brief
Materials Development Activities Brief
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol for incomplete abortion in Tanzania
Medical Abortion Program Brief
Perspectives on reproductive decision-making amongst HIV-infected individuals
Postpartum Hemorrhage Program Brief
Misoprostol for incomplete abortion in Mozambique
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol for Prevention of Postpartum Hemorrhage
Reproductive intentions among HIV-positive women and men
The supreme court and the partial-birth abortion ban act of 2003
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Methotrexate compared to misoprostol alone for early medical abortion
Can mifepristone medical abortion be simplified?
Mifepristone for late first trimester abortion
Alternatives to mifepristone for early medical abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Misoprostol PPH Treatment Study
Use of sequential serum hCG and sonography for medical abortion only when indicated
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Clostridium sordellii infection in medical abortion
FAQs on Fatal Infection and Medical Abortion - Technical Version
FAQ on Hormonal Contraception and HIV
PPH Misoprostol Adjunct Treatment Study
PPH Treatment Study in Pakistan
PPH Prevention Study in Pakistan
Regimens of misoprostol with mifepristone for early medical abortion
Issue Brief on Hormonal Contraception and HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Mifepristone medical abortion in Albania
Outlook Newsletter on Hormonal Contraception and HIV
Postpartum Hemorrhage: Responding to the Challenge
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Improving Current Therapies and Exploring New Options in Abortifacient Technology
FAQs on Fatal Infection and Medical Abortion - Summary
Relationship of Hormonal Contraception to HIV
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Misoprostol for Incomplete Abortion and Miscarriage
Reference List - Misoprostol for Early Abortion
Annotated Bibliography - Misoprostol for Early Abortion
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol for Women’s Health
Misoprostol for Early Abortion
Misoprostol: A New Addition to Post Abortion Care
Route of Misoprostol Administration